Medicare Enrolled
Dr. Mark Nyce, MD
Gastroenterology · Savannah, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nyce from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nyce?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nyce
Dr. Mark Nyce is a gastroenterology specialist in Savannah, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nyce performed 1,155 Medicare services across 1,022 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nyce received a total of $9,719 from 46 pharmaceutical and/or device companies across 516 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nyce is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 20% volume in GA
$9,719 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,155
Medicare services
Top 20% in GA for gastroenterology
1,022
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~58 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
318 | $62 | $275 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
183 | $198 | $943 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
159 | $84 | $391 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
118 | $63 | $600 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
91 | $66 | $793 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
75 | $60 | $210 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
39 | $113 | $1,556 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
33 | $111 | $507 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
33 | $165 | $747 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
32 | $69 | $336 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
26 | $99 | $400 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
21 | $161 | $747 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
15 | $130 | $747 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $132 | $588 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,719
Total received (2018-2024)
Avg $1,388/year across 7 years
Top 17% in GA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
516
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,703 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,592
2023
$1,846
2022
$2,234
2021
$1,319
2020
$622
2019
$1,091
2018
$1,015
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$627
Janssen Biotech, Inc.
$218
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$191
Takeda Pharmaceuticals U.S.A., Inc.
$85
PFIZER INC.
$76
Gilead Sciences, Inc.
$67
Organon Llc
$62
Celgene Corporation
$44
Merck Sharp & Dohme LLC
$41
Lilly USA, LLC
$36
GENZYME CORPORATION
$34
Ferring Pharmaceuticals Inc.
$22
Regeneron Healthcare Solutions, Inc.
$22
Ipsen Biopharmaceuticals, Inc
$20
Mallinckrodt Hospital Products Inc.
$19
Madrigal Pharmaceuticals
$16
Phathom Pharmaceuticals, Inc.
$13
Top 3 companies account for 65.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,131
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,401
Janssen Biotech, Inc.
$835
Gilead Sciences, Inc.
$763
PFIZER INC.
$670
Takeda Pharmaceuticals U.S.A., Inc.
$448
AbbVie Inc.
$421
AbbVie, Inc.
$322
Boston Scientific Corporation
$314
Celgene Corporation
$277
RedHill Biopharma Inc.
$253
Allergan Inc.
$219
Ferring Pharmaceuticals Inc.
$154
QOL Medical, LLC
$115
Ironwood Pharmaceuticals, Inc
$114
Nestle HealthCare Nutrition Inc.
$103
UCB, Inc.
$97
Merck Sharp & Dohme LLC
$92
Merck Sharp & Dohme Corporation
$82
Shionogi Inc
$74
Janssen Scientific Affairs, LLC
$73
Organon Llc
$62
GENZYME CORPORATION
$60
Shire North American Group Inc
$59
Intercept Pharmaceuticals, Inc.
$53
Alnylam Pharmaceuticals Inc.
$51
Regeneron Healthcare Solutions, Inc.
$43
Amgen Inc.
$41
Mallinckrodt Hospital Products Inc.
$38
Lilly USA, LLC
$36
Daiichi Sankyo Inc.
$31
Braintree Laboratories, Inc.
$30
Alexion Pharmaceuticals, Inc.
$29
Prometheus Laboratories Inc.
$27
Organon LLC
$25
Fresenius Kabi USA, LLC
$21
Ipsen Biopharmaceuticals, Inc
$20
Mylan Institutional Inc.
$18
Allergan, Inc.
$16
Celltrion USA Inc.
$16
Madrigal Pharmaceuticals
$16
Synergy Pharmaceuticals Inc
$14
Endo Pharmaceuticals Inc.
$14
Phathom Pharmaceuticals, Inc.
$13
AstraZeneca Pharmaceuticals LP
$13
IRONWOOD PHARMACEUTICALS, INC
$13
Top 3 companies account for 44.9% of all-time payments
Associated products mentioned in payments ›
APRISO · AVSOLA · Amitiza · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · EXALT Model D · Entyvio · Epclusa · GATTEX · GIVLAARI · General - Hemostasis · HUMIRA · Hulio · Humira · INFLECTRA · INJECTAFER · IQIRVO · Kanuma · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOVANTIK · Mavyret · Movantik · Mulpleta · NASCOBAL · OCALIVA · OMVOH · OXLUMO · PREPOPIK · REBYOTA · RELISTOR · RELISTOR ORAL · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP · SUPREP BOWEL PREP · Sucraid · Symproic · TERLIVAZ · TREMFYA · TRULANCE · Talicia · TheraSphere Y90 Glass Microspheres 10 GBq · Trulance · UCERIS · UCERIS TABLETS · VIBERZI · VOQUEZNA · Vemlidy · XELJANZ · XIFAXAN · XIFIXAN · YUFLYMA · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
29
Per 100K population
9.7
County median income
$69,575
Nearest hospital
SAVANNAH HEALTH SERVICES LLC DBA MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nyce is a clinical cardiology specialist, with above-average Medicare volume (top 20% in GA), with low-engagement industry engagement in the top 17% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nyce experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Nyce performed 318 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nyce receive payments from pharmaceutical companies?
Yes. Dr. Nyce received a total of $9,719 from 46 companies across 516 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nyce's costs compare to other gastroenterologists in Savannah?
Dr. Nyce's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nyce) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Savannah
Browse gastroenterologists in Savannah ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in GA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in GA
Which GA gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology